Suppressor of cytokine signalling 3 (SOCS3) turnover and regulation of human saphenous vein smooth muscle cell signalling and function
dc.contributor.advisor | Palmer, Timothy M. | |
dc.contributor.advisor | Riches-Suman, Kirsten | |
dc.contributor.advisor | Elies, Jacobo | |
dc.contributor.author | Moshapa, Florah T. | |
dc.date.accessioned | 2024-01-02T13:49:38Z | |
dc.date.available | 2024-01-02T13:49:38Z | |
dc.date.issued | 2021 | |
dc.identifier.uri | http://hdl.handle.net/10454/19744 | |
dc.description.abstract | Neointimal hyperplasia (NIH) is a cardiovascular disease characterised by increased smooth muscle cell (SMC) inflammation and proliferation. Suppressor of cytokine signalling 3 (SOCS3) limits Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathways involved in vascular remodelling but is limited by its short biological half-life. Therefore, mutation of all 9 Lys residues that are potential sites of ubiquitylation to Arg should produce a mutated SOCS3 resistant to ubiquitin-mediated proteasomal degradation (“Lys-less” SOCS3). This study hypothesise that enhancing SOCS3 stability and limiting JAK/STAT signalling may provide sustained inhibition of the vascular remodelling in NIH. Lentiviral transduction of WT and Lys-less SOCS3 in human saphenous vein (HSVSMCs) was highly efficient after 48 hours (>97%) and was sustained over 2 weeks. Lys-less SOCS3 was resistant to ubiquitylation contrary to WT-transduced HSVECs, and Lys-less SOCS3 was more stable (t1/2=4h) than WT (t1/2<4h) (n=6, P<0.001) in HSVSMCs. In HSVSMCs, both Lys-less SOCS3 and WT inhibited sIL-6Rα/IL-6 mediated STAT3 activation but not extracellular signal regulated protein kinase 1/2 (ERK1/2) by 80±7% (Lys-lessSOCS3/pSTAT3) and 74±6% (WT/pSTAT3) (n=3, P<0.05) and similarly inhibited PDGF-mediated STAT3 activation but not ERK1/2 by 67±17% (Lys-less SOCS3/pSTAT3) and 72±18% (WT/pSTAT3) (n=3, P<0.05). Functionally, Lys-less SOCS3 and WT were equivalent in inhibiting sIL-6Rα/IL-6 and PDGF-induced proliferation, whilst having no effects on PDGF-induced migration in HSVSMCs. Lys-less SOCS3 can be successfully transduced into primary HSVSMCs. It is more stable than WT yet retains its functional ability to ameliorate pro-inflammatory signalling and SMC proliferation, making it an attractive option for developing treatment of NIH. | en_US |
dc.description.sponsorship | University of Botswana | en_US |
dc.language.iso | en | en_US |
dc.rights | <a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><img alt="Creative Commons License" style="border-width:0" src="http://i.creativecommons.org/l/by-nc-nd/3.0/88x31.png" /></a><br />The University of Bradford theses are licenced under a <a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/">Creative Commons Licence</a>. | eng |
dc.subject | Neointimal hyperplasia (NIH) | en_US |
dc.subject | Cytokine signalling 3 (SOCS3) | en_US |
dc.subject | Janus kinase (JAK) | en_US |
dc.subject | JAK/STAT signalling | en_US |
dc.subject | Signal transducer and activator of transcription (STAT) | en_US |
dc.subject | Human saphenous vein | en_US |
dc.subject | Cell migration | en_US |
dc.subject | Cell proliferation | en_US |
dc.subject | Cardiovascular disease | en_US |
dc.subject | Smooth muscle cell | en_US |
dc.title | Suppressor of cytokine signalling 3 (SOCS3) turnover and regulation of human saphenous vein smooth muscle cell signalling and function | en_US |
dc.type.qualificationlevel | doctoral | en_US |
dc.publisher.institution | University of Bradford | eng |
dc.publisher.department | School of Pharmacy and Medical Sciences. Faculty of Life Sciences | en_US |
dc.type | Thesis | eng |
dc.type.qualificationname | PhD | en_US |
dc.date.awarded | 2021 | |
refterms.dateFOA | 2024-01-02T13:49:38Z |